Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
deal source : Www.biospace.com save search
$4.9B Vertex-Alpine Deal Highlights Continued 2024 M&A Upswing
Published: 2024-04-11 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.64%
H: 0.0%
C: 0.0%
deal
Merck Snaps Up Small Startup in $208M Deal, Seeks to Improve Safety of ADCs
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
ADCT | $4.76 -4.03% -0.84% 280K
|
Health Technology
|
| O: 0.4%
H: 7.17%
C: 1.39%
merck
AZ-Fusion Deal, BMS $14B Karuna Purchase Highlight 2024 M&A Upswing
Published: 2024-03-19 (Crawled : 14:30) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Monday, February 12, 2024
Published: 2024-02-05 (Crawled : 15:00) - biospace.com/
CDXC | $3.79 -4.53% -4.61% 190K
|
Process Industries
|
| O: -1.97%
H: 5.37%
C: 4.03%
Can-Fite Expands the Out-Licensing Deal with Ewopharma to Include the Pancreatic Cancer Indication
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
CANF | $2.02 3.06% -2.48% 10K
|
Health Technology
|
| O: 5.24%
H: 2.71%
C: -4.75%
cancer pancreatic deal
Cormorant Launches Second SPAC Following MoonLake Deal with $100M IPO
Published: 2024-01-19 (Crawled : 17:00) - biospace.com/
IXAQ | $11.295 -0.22% 0.04% 20K
|
n/a
| Email alert
Add to watchlist
spac deal
7 Deals Emerge During JPM Week in Strong Start to 2024
Published: 2024-01-16 (Crawled : 14:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
start week
Precision BioSciences Completes License Deal with TG Therapeutics for Cell Therapy Azer-Cel in Treatment of Autoimmune Diseases
Published: 2024-01-09 (Crawled : 13:30) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: -8.22%
H: 9.05%
C: 7.47%
DTIL | $10.77 -6.43% -6.87% 71K
|
Health Technology
|
| O: 10.0%
H: 14.23%
C: 0.09%
license cell treatment deal therapeutics therapy
Failed Illumina and Sanofi Deals Shine Light on FTC Antitrust Crackdown
Published: 2023-12-20 (Crawled : 16:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.39%
H: 1.49%
C: 0.32%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
sanofi
Vanda Buys US, Canadian Rights to J&J’s MS Drug Ponvory in $100M Deal
Published: 2023-12-08 (Crawled : 17:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: 2.06%
H: 0.82%
C: 0.82%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
drug ponvory deal
Samsung Bioepis, J&J Ink Settlement and License Deal for Stelara Biosimilar
Published: 2023-11-30 (Crawled : 20:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.6%
H: 1.89%
C: 1.58%
biosimilar license deal stelara
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 1.4K
|
Health Technology
|
| O: -0.35%
H: 0.0%
C: 0.0%
TEVA | $12.78 -3.03% -0.24% 9M
|
Health Technology
|
| O: -0.52%
H: 3.73%
C: 1.87%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -1.09%
H: 0.0%
C: 0.0%
disease treatment collaboration teva deal
Deals, Dupixent and GLP-1 drug shortages
Published: 2023-11-29 (Crawled : 15:30) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: -0.15%
H: 0.07%
C: -0.66%
drug dupixent
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow on Tuesday, November 14, 2023
Published: 2023-11-09 (Crawled : 15:30) - biospace.com/
CDXC | $3.79 -4.53% -4.61% 190K
|
Process Industries
|
| O: 0.0%
H: 0.0%
C: -11.25%
GSK Inks $1B Deal Securing Rights to Arrowhead, J&J’s Hepatitis B Drug
Published: 2023-11-01 (Crawled : 17:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.99%
H: 0.0%
C: 0.0%
hepatitis drug deal
Sanofi, Teva Ink Potential $1.5B Deal Aimed at Blockbuster IBD Drug
Published: 2023-10-04 (Crawled : 15:30) - biospace.com/
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 1.07%
H: 0.0%
C: 0.0%
drug teva deal potential
AbbVie Ends I-Mab Deal for CD47 Antibody Compounds, Products
Published: 2023-09-25 (Crawled : 15:00) - biospace.com/
IMAB | $1.795 -0.83% -0.84% 140K
|
Health Technology
|
| O: 0.83%
H: 5.79%
C: 5.79%
cd47 abbvie antibody deal
Tentarix Biotherapeutics Completes Series B Financing Bringing Total Equity and Upfront Deal Consideration to $132 Million
Published: 2023-09-06 (Crawled : 15:00) - biospace.com/
GILD | News | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: -0.05%
H: 0.03%
C: -1.17%
series total deal
ChromaDex to Participate in Renmark’s Virtual Non-Deal Roadshow Series
Published: 2023-08-07 (Crawled : 13:00) - biospace.com/
CDXC | $3.79 -4.53% -4.61% 190K
|
Process Industries
|
| O: 0.0%
H: 0.0%
C: -1.22%
Week in Review: Licensing Deals, M&A, EU Regulators on a Tear, Latest in IRA ...
Published: 2023-07-14 (Crawled : 21:00) - biospace.com/
PRGO | $29.94 -0.33% 0.0% 970K
|
Health Technology
|
| O: 4.6%
H: 0.66%
C: -2.13%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.23%
H: 0.66%
C: 0.43%
week
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $1.45 5.84% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.421 97.65% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.509 23.81% 45.26% 90K
|
GDHG | $0.263 21.76% 40.66% 3.1M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.8 65.02% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.